Your browser doesn't support javascript.
loading
Inflammasome Signaling: A Novel Paradigm of Hub Platform in Innate Immunity for Cancer Immunology and Immunotherapy.
Li, Ying; Lv, Jiao; Shi, Weikai; Feng, Jia; Liu, Mingxi; Gan, Shenao; Wu, Hongjin; Fan, Weiwei; Shi, Ming.
Afiliação
  • Li Y; School of Life Science and Technology, Harbin Institute of Technology, Harbin, China.
  • Lv J; International Research Center for Regenerative Medicine, BOAO International Hospital, Qionghai, China.
  • Shi W; School of Life Science and Technology, Harbin Institute of Technology, Harbin, China.
  • Feng J; School of Life Science and Technology, Harbin Institute of Technology, Harbin, China.
  • Liu M; School of Life Science and Technology, Harbin Institute of Technology, Harbin, China.
  • Gan S; School of Life Science and Technology, Harbin Institute of Technology, Harbin, China.
  • Wu H; School of Life Science and Technology, Harbin Institute of Technology, Harbin, China.
  • Fan W; International Research Center for Regenerative Medicine, BOAO International Hospital, Qionghai, China.
  • Shi M; Department of Infectious and Medicine, Heilongjiang Provincial Hospital, Harbin, China.
Front Immunol ; 12: 710110, 2021.
Article em En | MEDLINE | ID: mdl-34421915

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inflamassomos / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inflamassomos / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Suíça